Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2021 / Cilt: 27 - Sayı: 6

The utility of serum miRNA-93 and miRNA-191 levels for determining injury severity in adults with multiple blunt trauma

Pages
631–638
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, an optimal cutoff value for serum miRNA-191 was identified, with values

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: Various scoring systems have been developed to determine the trauma severity and prognosis of patients following multiple blunt trauma (MBT).
📊
Key Findings & Data:Thus, this study measured the expression of miRNA-93 and -191 in the serum of adults with MBT and examined the correlations of Injury Severity Score (ISS) and Revised Trauma Score values with serum miRNA-93 and -191 levels in these patients with the aim of predicting trauma severity based on the miRNA levels.
💡
Conclusion & Impact:However, an optimal cutoff value for serum miRNA-191 was identified, with values
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

BACKGROUND: Various scoring systems have been developed to determine the trauma severity and prognosis of patients following multiple blunt trauma (MBT). However, these scoring systems do not provide exactly the desired severity assessment. In recent years, serum concentration of many specific microRNAs (miRNAs), especially for head trauma, has been shown to play an important role in determining the diagnosis, severity, and prognosis of injury. To date, however, no studies have investigated serum miRNAs in patients with MBT. Thus, this study measured the expression of miRNA-93 and -191 in the serum of adults with MBT and examined the correlations of Injury Severity Score (ISS) and Revised Trauma Score values with serum miRNA-93 and -191 levels in these patients with the aim of predicting trauma severity based on the miRNA levels. METHODS: This prospective case–control study enrolled 50 consecutive adults with MBT and age- and sex-matched 60 healthy controls. The patients were divided into ISS >16 (Group 1, major or severe trauma) and ISS ≤16 (Group 2, minor or mild-moderate trauma) groups. Serum miRNA-93 and -191 levels were assessed using quantitative real-time reverse transcription-PCR. We evaluated whether the miRNAs were differentially expressed in major and minor MBT patients and determined their utility for assessing the severity of injury. RESULTS: The mean serum miRNA-93 and -191 levels were significantly elevated in the patients compared to the controls and were higher in patients with ISS >16 compared to those with ISS ≤16, although the difference was not significant. In the patients with multitrauma, ISS was significantly, negative and weak correlated with serum miRNA-191 level (rho=−0.320, p=0.023) but not with the serum miRNA-93 level. No optimal cutoff for the serum miRNA-93 level was found with respect to trauma severity (AUC 0.617, [0.455–0.779]). However, an optimal cutoff value for serum miRNA-191 was identified, with values

🔖

Cite This Article

Çalık, M., Ergenç, H., Söğüt, Ö., Metiner, M., Kaplan, O., Çakmak, S., Ümit, T. B., Süsgün, S., Akbas, F. (2022). The utility of serum miRNA-93 and miRNA-191 levels for determining injury severity in adults with multiple blunt trauma. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 27 - Sayı: 6, 631–638. https://ajindex.com/articles/644083

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: An overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006;60:S3–11
  2. Galvagno SM Jr., Nahmias JT, Young DA. Advanced trauma life support® update 2019: Management and applications for adults and special populations. Anesthesiol Clin 2019;37:13–32
  3. Wisner DH. History and current status of trauma scoring systems. Arch Surg 1992;127:111–7
  4. Galvagno SM Jr., Massey M, Bouzat P, Vesselinov R, Levy MJ, Millin MG, et al. Correlation between the revised trauma score and injury severity score: Implications for prehospital trauma triage. Prehosp Emerg Care 2019;23:263–70
  5. Deng Q, Tang B, Xue C, Liu Y, Liu X, Lv Y, et al. Comparison of the ability to predict mortality between the ınjury severity score and the new ınjury severity score: A meta-analysis. Int J Environ Res Public Health 2016;13:E825
  6. Javali RH, Krishnamoorthy, Patil A, Srinivasarangan M, Suraj, Sriharsha. Comparison of Injury Severity Score, New Injury Severity Score, Revised Trauma Score and Trauma and Injury Severity Score for Mortality Prediction in Elderly Trauma Patients. Indian J Crit Care Med 2019;23(2):73–7
  7. Bolorunduro OB, Villegas C, Oyetunji TA, Haut ER, Stevens KA, Chang DC, et al. Validating the ınjury severity score (ISS) in different populations: ISS predicts mortality better among Hispanics and females. J Surg Res 2011;166:40–4
  8. Yang Z, Zhong L, Xian R, Yuan B. MicroRNA-223 regulates inflammation and brain injury via feedback to NLRP3 inflammasome after intracerebral hemorrhage. Mol Immunol 2015;65:267–76
  9. Bache S, Rasmussen R, Rossing M, Hammer NR, Juhler M, Friis-Hansen L, et al. Detection and quantification of microRNA in cerebral microdialysate. J Transl Med 2015;13:149
  10. Martinez B, Peplow PV. MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury. Neural Regen Res 2017;12:1749– 61
  11. Meyer SU, Pfaffl MW, Ulbrich SE. Normalization strategies for microrna profiling experiments: A “normal” way to a hidden layer of complexity? Biotechnol Lett 2010;32:1777–88
  12. Mahdipour M, van Tol HT, Stout TA, Roelen BA. Validating reference microRNAs for normalizing qRT-PCR data in bovine oocytes and preimplantation embryos. BMC Dev Biol 2015;15:25
  13. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human sol